Skip to main content
. 2024 Nov 24;23:100490. doi: 10.1016/j.lrr.2024.100490

Fig. 1.

Fig 1

Overall survival (OS) according to treatment regimen: ESA (erythropoiesis stimulating agent), HMA (hypomethylating agent).